Diabetes Drug - Metformin

According to U.S. researchers, diabetics who took metformin exhibit lower risk of developing pancreatic cancer than their counterparts; the risk being 62 percent lesser. Metformin is an oral anti-diabetic drug which function is to increase the efficiency of insulin in the body.

Having said this, those patients who used insulin or other drugs to increase insulin production in the body for treating diabetes are at a far higher risk; this statement was echoed in the speech of lead researcher Donghui Li from The University of Texas M.D. Anderson Cancer Center. Metformin is being utilized for tackling type 2 diabetes mainly cause by eccentric diet pattern and lack of exercises in about 90 percent of diabetes cases globally.

Insulin secretagogues and insulin have been associated with the increase risk of pancreatic cancer. Those who undertook an insulin course were 5 times more vulnerable and those who took secretagogues of insulin were 2.55 more susceptible to developing pancreatic carcinoma, claimed the study. Insulin leads to cell growth and this aids the malignant cells too.

This kind of interaction can be suggestive in describing the findings of four just concluded studies (published in Diabetologia). The journal says that notable Sanofi-Aventis insulin drug Lantus is being linked to cancer enhancing causes. Having said this, Sanofi Aventis said that it needs more research in the given area.

A well spanned study on 1800 people was undertaken, this group amalgamated 900 with pancreatic cancer and about 350 with diabetes. The group went through an elaborate analysis of their health history, gender, age and race. Through Li confirmed that the study could only be conclusive if its wings were broadened further in terms of number of people included, yet it is good enough to show the use of metformin as an agent of chemoprevention.

Scores of diabetic medicines rummage through the market. Metformin is one of the general anti-diabetic drugs, particularly in obese people and those with normal kidney function. It is augmented with Amaryl if patients are not able to control the blood sugar levels well. The American Diabetes Association is already keeping an eye on it and recommended metformin which it claims to lower LDL cholesterol and reduce the risk of heart disease.